Idexx Laboratories (IDXX) Free Cash Flow (2009 - 2026)

Idexx Laboratories (IDXX) has reported Free Cash Flow for 18 consecutive years, with $258.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Free Cash Flow rose 24.06% year-over-year to $258.0 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 32.98% YoY), while the FY2025 annual figure was $1.1 billion, up 30.82% from the prior year.
• Free Cash Flow came in at $258.0 million for Q1 2026 at Idexx Laboratories, up from $237.9 million in the prior quarter.
• The five-year high for Free Cash Flow was $459.7 million in Q3 2025, with the low at $66.5 million in Q2 2022.
• Average Free Cash Flow over 5 years is $193.5 million, with a median of $183.4 million recorded in 2024.
• Across the five-year window, Free Cash Flow tumbled 71.18% in 2022 and surged 236.19% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at $124.2 million in 2022, then jumped by 74.96% to $217.3 million in 2023, then grew by 7.12% to $232.8 million in 2024, then rose by 2.19% to $237.9 million in 2025, then grew by 8.46% to $258.0 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $258.0 million, $237.9 million, and $459.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.